Compounds, Formulations, And Methods For Treating Or Preventing Rosacea


In methods, compounds, and topical formulations for treatment of rosacea incorporating compounds represented by the formulas below: wherein each of R<SUB>1</SUB>, R<SUB>2</SUB>, and R<SUB>3 </SUB>is independently hydrogen, hologen, alkyl, or alkoxy; each of R<SUB>4 </SUB>and R<SUB>5 </SUB>is independently hydrogen, alkyl, or alkoxy; and each of R<SUB>6 </SUB>and R<SUB>7 </SUB>is independently hydrogen, nitro, alkyl, or alkoxy; wherein each of A<SUB>1</SUB>, A<SUB>3</SUB>, and A<SUB>4 </SUB>is independently hydrogen or alkyl; and A<SUB>2 </SUB>is independently hydrogen or hydroxy; and wherein each of B<SUB>1</SUB>, B<SUB>2</SUB>, and B<SUB>3 </SUB>is independently hydrogen, hydroxy, or alkoxy; and each of B<SUB>4 </SUB>and B<SUB>5 </SUB>is independently hydrogen or alkyl, applying such compounds topically as sprays, mists, aerosols, solutions, lotions, gels, creams, ointments, pastes, unguents, emulsions, and suspensions to treat rosacea and its symptoms.

Download PDF
Document Preview
Document History
  • Publication: Oct 21, 2008
  • Application: May 25, 2004
    US US 85358504 A
  • Priority: May 25, 2004
    US US 85358504 A
  • Priority: May 27, 2003
    US US 47361103 P

Sign in to the Lens